Larimar Therapeutics (LRMR) Total Debt (2016 - 2020)
Historic Total Debt for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to $6.7 million.
- Larimar Therapeutics' Total Debt fell 5011.83% to $6.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.7 million, marking a year-over-year decrease of 5011.83%. This contributed to the annual value of $8.5 million for FY2019, which is 4426.08% down from last year.
- Per Larimar Therapeutics' latest filing, its Total Debt stood at $6.7 million for Q1 2020, which was down 5011.83% from $8.5 million recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Total Debt registered a high of $20.2 million during Q1 2018, and its lowest value of $1.2 million during Q3 2016.
- For the 5-year period, Larimar Therapeutics' Total Debt averaged around $11.3 million, with its median value being $11.9 million (2019).
- In the last 5 years, Larimar Therapeutics' Total Debt plummeted by 7116.77% in 2016 and then crashed by 2407.5% in 2018.
- Quarter analysis of 5 years shows Larimar Therapeutics' Total Debt stood at $1.2 million in 2016, then soared by 1566.67% to $20.0 million in 2017, then dropped by 24.08% to $15.2 million in 2018, then crashed by 44.26% to $8.5 million in 2019, then fell by 20.29% to $6.7 million in 2020.
- Its Total Debt stands at $6.7 million for Q1 2020, versus $8.5 million for Q4 2019 and $10.2 million for Q3 2019.